All Updates

All Updates

icon
Filter
Partnerships
Dante Genomics and AWS collaborate to launch GenAI platform for precision medicine and clinical genomics
Precision Medicine
Sep 20, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Product updates
Uber releases five new features for holiday travel season
Travel Tech
Yesterday
Precision Medicine

Precision Medicine

Sep 20, 2023

Dante Genomics and AWS collaborate to launch GenAI platform for precision medicine and clinical genomics

Partnerships

  • Genetic testing company Dante Genomics and Amazon Web Services (AWS) have collaborated to bring generative AI (GenAI) to the clinical care of patients with genomic diseases.

  • The collaboration will leverage AWS' Amazon Bedrock platform to build large language models (LLMs) for clinical genomics. The partnership aims to apply genomic data in personalized medicine by enabling access and navigation of genomic reports to extract phenotypes of interest and identify related genetic conditions.

  • Italy-based Dante Genomics is a worldwide genomics information company that focuses on whole genome sequencing and software utilization. With this platform, the company improves patient outcomes, enhances disease prevention, advances diagnostic capabilities, and enables personalized medicine.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.